Personalizing Therapy and Assessing Risk in Hodgkin Lymphoma

EP. 1: Dr Evens on Personalizing Therapy for Patients with Hodgkin Lymphoma

July 2nd 2025

Andrew Evens, DO, MBA, MSc, discusses the HOLISTIC consortium, which aims to gather and harmonize global Hodgkin lymphoma data from clinical trials and registries.

EP. 2: Dr Evens Discusses New Prognostic Model for Early-Stage Hodgkin Lymphoma

ByAndrew M. Evens, DO, MBA, MSc

July 10th 2025

Andrew Evens, DO, MBA, MSc, discusses a modern way of stratifying risk in patients with early-stage Hodgkin lymphoma.

EP. 3: Predictive Model Aims to Personalize Hodgkin Lymphoma Treatment

ByAndrew M. Evens, DO, MBA, MSc

July 11th 2025

A new risk model uses objective clinical data to predict cure or relapse in Hodgkin lymphoma, with future plans to guide treatment and survivorship care.